Energy Leads, Tech Cools: A Market Split Between Hormuz and Rate Relief

The opening snapshot on Friday, August 14 is one of the cleaner rotation prints you’ll see in a tape sitting at record highs. The S&P 500 (SPY) is fractionally lower at $776.46, down 0.18%^[1], and the Nasdaq 100 (QQQ) has slipped 0.38%^[1] — but the action is not in the index level. It is in the composition. Energy is the day’s leadership, semiconductors are the laggard despite strong earnings, small caps are outperforming large caps, and a benign July CPI has taken a September rate hike off the table. Three of these four moves are internally consistent. The semiconductor lag is the one worth interrogating.

Oil and the Strait of Hormuz

The cleanest signal on the tape is energy. XLE is up 1.48%^[1], with Chevron (CVX) up 1.69% to $201.05 and ExxonMobil (XOM) up 1.37% to $160.79^[1]. The driver is geopolitical and deteriorating. The Strait of Hormuz remains effectively blocked, according to the Persian Gulf Strait Authority, which issued a statement that the waterway “will not be reopened until Iran’s conditions are accepted”^[2]. This contradicts President Trump’s repeated assertions that the U.S. has “total control” over the strait^[2]. Transit has fallen to near three-month lows^[2], and the U.S. military fired Hellfire missiles from a helicopter to disable a Panama-flagged vessel it said was breaking the blockade^[2]. A worsening oil spill near Oman and attacks on shipping in the Gulf of Oman have compounded supply-disruption fears^[3].

The question a balanced analyst asks here is whether the market is pricing the probability of a sustained Hormuz closure or the realization of one. Saudi Arabia is reportedly rerouting exports through Mediterranean pipelines to avoid Red Sea attacks^[3], and OPEC+ approved a September production increase of roughly 188,000 barrels per day, completing the unwinding of voluntary cuts^[3]. That supply buffer is meaningful — but it only offsets disruption if it can physically reach market, and the Hormuz standoff raises exactly that question.

CPI and the Fed: Rate-Hike Risk Fades

The macro backdrop shifted constructively midweek. July CPI rose just 0.1% month-over-month, bringing the annual rate to 3.4%^[4]. Core CPI rose 0.2% on the month and 2.5% year-over-year, both in line with Wall Street consensus^[4]. Traders subsequently reduced the odds that the Federal Reserve will raise interest rates at its September meeting^[4].

This matters because the Fed’s last decision on July 29 was a 9-3 hold with three dissents in favor of higher rates^[4] — a fractious split that left the market uncertain about the next move. Chairman Kevin Warsh has argued for giving markets fewer forward signals^[4], which itself is a signal: the Fed wants optionality, and the CPI print gave them cover to keep it.

The FRED macro snapshot as of July 2026 reinforces the “on hold” read. The Fed funds rate sits at 3.63%^[5], the 10-year Treasury yield is at 4.68%^[5], and the 2s10s yield curve is positively sloped at +0.48%^[5] — un-inverted, which historically is the transition pattern that accompanies the late-cycle phase rather than an imminent recession. The unemployment rate at 4.1%^[5] and real GDP growth at 2.1% YoY^[5] describe an economy that is neither booming nor breaking. The VIX at 15.28^[5] and HY credit spreads at 2.71%^[5] confirm that market participants are pricing minimal tail risk.

The historical analogs the FRED nearest-neighbor search surfaces are instructive: the closest matches cluster around mid-2006 and late-2007^[5]. In 2006 the economy was mid-cycle with a positively sloped curve and no recession. By late 2007 the curve had steepened and the cycle was within months of turning. The analogy is a warning, not a forecast — but it is the right frame for asking whether this expansion has more room to run or is quietly aging.

The Semiconductor Cooldown

Here is where the tape gets interesting. The VanEck Semiconductor ETF (SMH) is down 0.87%^[1], and it has fallen roughly 18% over the past month after a 75% one-year rally^[6]. This decline is happening despite strong Q2 earnings across the AI hardware supply chain. As Morningstar noted, “AI hardware stocks, from memory chipmakers to factory firms, are seeing prices fall despite strong second-quarter earnings,” with sky-high expectations and elevated valuations leaving stocks “priced for perfection”^[6]. Investors are booking profits in semiconductor funds as the AI trade cools^[6].

There are two ways to read this. The first is the base-rate interpretation: after a 75% rally, a 18% pullback is a routine de-risking, not a structural break. Earnings are landing; the multiples are compressing. The second is the early-warning interpretation: when stocks with strong fundamentals sell off on good news, it often signals that the marginal buyer has exhausted their conviction, and the next leg depends on guidance rather than beats. Both can be true simultaneously — the distinction matters for positioning, not for diagnosis.

Individual mega-caps are mixed. NVIDIA (NVDA) is essentially flat at $225.42^[1], a sign that the selling pressure may be concentrated in the second-tier names rather than the bellwether. Microsoft (MSFT) is up 0.22%^[1], and Apple (AAPL) is barely positive^[1]. The Magnificent Seven is not uniformly weak — the cooling is narrower than the SMH headline suggests.

GLP-1 Wobble

Eli Lilly (LLY) is the day’s notable pharma decliner, down 1.95% to $1,185.41^[1] — a move that extends the volatility the stock has seen since late July. On July 30, LLY fell as much as 4.5% after Cigna’s CFO warned that GLP-1 prescription drug growth slowed in the second quarter^[7]. The concern is that the deceleration in prescription trends signals a plateau in the obesity-drug supercycle, even as Lilly’s own Q2 results told a different story: revenue surged 48% to $23.0 billion, driven by Mounjaro and Zepbound^[7], and management raised full-year revenue guidance to $85–$87 billion^[7].

This is a classic expectations-versus-delivery gap. The earnings are exceptional by any historical standard. The stock reaction is about the second derivative — whether the growth rate of growth is slowing. Lilly’s widening lead over Novo Nordisk in the GLP-1 space^[7] means the competitive moat is intact; the question is whether the total addressable market is as deep as the valuation implies.

Sector Snapshot at Midday

All quotes as of 12:07 ET, August 14, 2026, source: FMP, 15-minute delay.

What to Watch Next

• Hormuz escalation path. The gap between Trump’s “total control” rhetoric and the Persian Gulf Strait Authority’s “remains blocked” statement is widening^[2]. Any confirmed reopening or further military engagement shifts energy prices — and the XLE trade — decisively in either direction.

• September FOMC. The July CPI took a hike off the table^[4], but three FOMC members dissented for higher rates at the last meeting^[4]. The next CPI print in September will determine whether the hawks regain momentum or the hold consensus solidifies.

• Semiconductor guidance season. The Q2 earnings beats are in the books. What moves SMH from here is Q3 guidance and capex commentary from hyperscalers. If AI infrastructure spending holds, the 18% pullback from 75% rally looks like a healthy correction. If guidance disappoints, it looks like the beginning of a longer unwinding.

• GLP-1 prescription trends. Lilly’s own data is strong, but the Cigna signal about slowing prescription growth^[7] needs confirmation or refutation from the next batch of pharmacy benefit manager commentary.

The base rate for a market at record highs with a VIX of 15 is continued grind, not a sharp break. But the internal rotation — energy up, semis down, small caps leading — is the kind of divergence that either resolves into a new leadership cycle or warns that the rally is narrowing. The evidence does not yet force a choice between those readings. It is the right moment to watch the composition, not just the level.